Sex‐specific differences have been definitively demonstrated in cardiovascular (CV)
diseases. These differences can also impact on the effects of CV therapies. Female sex is …

Sex and gender differences have been reported in atrial fibrillation (AF), especially in
relation to differences in thromboembolic and bleeding risks. More recently …

Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with an increased
thromboembolic risk. The impact of the female sex as an independent risk factor for …

Introduction Limited information exists on gender-related differences in the safety and
efficacy of non-vitamin K antagonist oral anticoagulants (NOACs). Aim of the Study To …

Studies comparing gender-specific outcomes in patients with atrial fibrillation (AF) have
reported conflicting results. Gender differences in cerebrovascular accident/systemic …

Aims Data on gender differences in oral anticoagulation for stroke prevention in patients with
atrial fibrillation are conflicting, largely limited to regional reports and vitamin K antagonist …

Atrial fibrillation (AF), one of the most prevalent supra-ventricular arrhythmia in adults, is
related to a substantial increase in the risk of thromboembolic events requiring tailored …

Background: Stroke risk in atrial fibrillation is assessed by using the CHA2DS2-VASc score.
Sex category (Sc, ie, female sex) confers 1 point on CHA2DS2-VASc. We hypothesized that …

Stroke prevention is a key clinical concern in the management of patients with atrial
fibrillation. Oral anticoagulation treatment reduces the risk of disabling stroke, but the …

Atrial Fibrillation (AF) is accompanied by an increased risk for thromboembolic events in
most affected patients. Current guidelines therefore recommend antithrombotic therapy with …